The effect of probiotic and antibiotic drugs on diarrhea

Comparison of the effects of fructo-oligosaccharide and metronidazole on the control of infectious diarrhea in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170316033099N8

Enrollment

120

Registered

2019-03-26

Start date

2017-09-23

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infectious diarrhea. Other and unspecified gastroenteritis and colitis of infectious origin

Interventions

Intervention 1: Intervention group 1 (metronidazole): metronidazole made by Alborz Company, 10 milligrams per kilogram body weight, three times daily until recovery. Intervention 2: Intervention group

Eligibility

Sex/Gender

All

Age

60 Months to 180 Months

Inclusion criteria

Inclusion criteria: Children suffering from infectious diarrhea Hospitalization in Amir al-Momenin Hospital of Zabol Age between 60 and 180 months Informed consent of the child's guardian

Exclusion criteria

Exclusion criteria: Hepatic failure Renal failure Patients with autoimmune disease

Design outcomes

Primary

Measure	Time frame
Infectious diarrhea. Timepoint: Every four hours from the first drug administration until recovery. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohadeseh Nikbakht

Zabol University of Medical Sciences

mohadeseh_nikbakht@zbmu.ac.ir+98 54 3223 0768

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026